BioCentury
ARTICLE | Financial News

Heat Biologics bumps up share number for IPO

July 8, 2013 11:34 PM UTC

Cancer company Heat Biologics Inc. (Chapel Hill, N.C.) amended its IPO and now plans to sell 2.3 million shares at $10-$12. At the $11 midpoint, Heat Biologics would raise $25 million and be valued at $64.4 million. Cantor Fitzgerald and Aegis Capital are underwriters. In May, Heat Biologics said it planned to sell 1.7 million shares at $10-$12 after proposing to raise up to $20 million in the offering (see BioCentury Extra, May 20). ...